Regulus Therapeutics
RGLS
#8838
Rank
โ‚น9.54 B
Marketcap
โ‚น144.04
Share price
-6.39%
Change (1 day)
-31.53%
Change (1 year)

Regulus Therapeutics (RGLS) - Total assets

Total assets on the balance sheet as of December 2024 : โ‚น7.19 Billion

According to Regulus Therapeutics's latest financial reports the company's total assets are โ‚น7.19 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Regulus Therapeutics - Total assets on balance sheet (from 2011 to 2024)

Total assets by year

Year Total assets Change
2024-12-31โ‚น7.22 B182.1%
2023-12-31โ‚น2.55 B-33.78%
2022-12-31โ‚น3.86 B-24.13%
2021-12-31โ‚น5.09 B85.27%
2020-12-31โ‚น2.75 B-8.35%
2019-12-31โ‚น3.00 B53.67%
2018-12-31โ‚น1.95 B-60.7%
2017-12-31โ‚น4.96 B-27.37%
2016-12-31โ‚น6.84 B-27.04%
2015-12-31โ‚น9.37 B-13.73%
2014-12-31โ‚น10.86 B42.95%
2013-12-31โ‚น7.60 B34.14%
2012-12-31โ‚น5.66 B149.86%
2011-12-31โ‚น2.26 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
โ‚น6.378 T 88,543.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น11.812 T 164,060.56%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚น2.397 T 33,220.23%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น8.893 T 123,484.89%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น362.44 B 4,936.74%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น8.68 B 20.73%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น7.915 T 109,904.63%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA